Nasdaq:US$15.72 (+0.06) | HKEX:HK$24.75 (+0.75) | AIM:£2.47 (+0.03)
新闻中心及演示文稿
上一篇文章   |   下一篇文章
公告及新闻稿, 集团 | 2023-04-11

2022年年报及股东周年大会通告(只备英文版本)

Hong Kong, Shanghai, & Florham Park, NJ — Tuesday, April 11, 2023: HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM: HCM; HKEX: 13) today announces that its 2022 Annual Report together with the Notice of Annual General Meeting and the Form of Proxy (“AGM Materials”) will be posted to shareholders on April 12, 2023 who have elected to receive the AGM Materials in printed form. The documents can also be accessed from the HUTCHMED website (www.hutch-med.com).

 

The 2023 Annual General Meeting (“AGM”) will be an electronic/hybrid meeting to be held at 1st Floor, Harbour Grand Kowloon, 20 Tak Fung Street, Hung Hom, Kowloon, Hong Kong on Friday, May 12, 2023 at 5:00 pm Hong Kong Time (10:00 am London Time), with online access through an online platform as detailed in the AGM Materials.

 

About HUTCHMED

HUTCHMED (Nasdaq/AIM: HCM; HKEX: 13) is an innovative, commercial-stage, biopharmaceutical company. It is committed to the discovery and global development and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. It has more than 5,000 personnel across all its companies, at the center of which is a team of about 1,800 in oncology/immunology. Since inception HUTCHMED has focused on bringing drug candidates from in-house discovery to patients around the world, with its first three oncology drugs now approved and marketed in China. For more information, please visit: www.hutch-med.com or follow us on LinkedIn.

 

联络方法

投资者谘询

李健鸿,高级副总裁 +852 2121 8200
郑嘉惠,副总裁 +1 (973) 306 4490

媒体谘询

美洲:Brad Miles, Solebury Strategic Communications +1 (917) 570 7340(手机)
bmiles@soleburystrat.com
欧洲:Ben Atwell / Alex Shaw, FTI Consulting +44 20 3727 1030 /
+44 7771 913 902(手机)/
+44 7779 545 055(手机)
HUTCHMED@fticonsulting.com
亚洲:周怡,博然思维集团 +852 9783 6894(手机)
HUTCHMED@brunswickgroup.com
中国大陆及香港:Cindy Lung / Corinne Ho,纵横公关集团 +852 9282 4640 (手机) /
+852 6198 4265 (手机)
SPRG_HUTCHMED@sprg.com.hk

提名顾问

Atholl Tweedie / Freddy Crossley,
Panmure Gordon (UK) Limited
+44 (20) 7886 2500